• Font Size    
E-mail

Close Window E-mail This Page

Kids' Flu Drugs Could Cause Neurological Problems

Required fields are marked with an asterisk(*)



The information you provide will be used only to send the requested e-mail and will not be used to send any other e-mail communications. Read more in our Privacy Policy

Send E-mail

   Print     Share +   

Kids' Flu Drugs Could Cause Neurological Problems

FDA Recommends New Label Warnings For amiflu And Relenza

WASHINGTON (CBS) ― Federal health regulators are recommending new label warnings about neurological problems on a pair of children's flu drugs.

The Food and Drug Administration has released its safety review of Roche's Tamiflu and GlaxoSmithKline's Relenza. The FDA opened a safety probe of Tamiflu in 2005 after receiving reports of children experiencing hallucinations and convulsions.

Twenty-five patients under the age of 21 have died while taking the drug, most of them in Japan. Five died from "falling from windows or balconies or running into traffic."

No deaths have been connected with Relenza, but regulators say children taking the drug have shown similar neurological problems.

Tamiflu is a prescription medication designed to treat influenza in patients 1 year or older. Relenza is recommended for patients at least 7 years old.

An outside group of pediatric experts is scheduled to open its own safety review next week.

(© 2009 CBS Broadcasting Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.)